X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5656) 5656
Publication (283) 283
Book Review (77) 77
Book / eBook (40) 40
Book Chapter (30) 30
Newsletter (22) 22
Magazine Article (16) 16
Conference Proceeding (11) 11
Web Resource (6) 6
Dissertation (5) 5
Data Set (3) 3
Newspaper Article (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4706) 4706
male (2995) 2995
female (2712) 2712
dyskinesia, drug-induced - etiology (2105) 2105
antipsychotic agents - adverse effects (2031) 2031
middle aged (2007) 2007
adult (1749) 1749
dyskinesia, drug-induced - drug therapy (1567) 1567
psychiatry (1512) 1512
aged (1468) 1468
schizophrenia - drug therapy (1360) 1360
clinical neurology (1303) 1303
parkinson disease - drug therapy (1180) 1180
levodopa - adverse effects (1166) 1166
index medicus (1165) 1165
antipsychotic agents - therapeutic use (1110) 1110
neurosciences (1080) 1080
animals (1069) 1069
parkinson's disease (928) 928
dyskinesia, drug-induced - physiopathology (860) 860
antiparkinson agents - adverse effects (816) 816
pharmacology & pharmacy (809) 809
tardive dyskinesia (763) 763
dyskinesia, drug-induced - diagnosis (717) 717
schizophrenia (678) 678
dose-response relationship, drug (652) 652
dyskinesia (641) 641
levodopa - therapeutic use (549) 549
rats (530) 530
movement disorders (506) 506
tardive-dyskinesia (484) 484
treatment outcome (472) 472
antiparkinson agents - therapeutic use (467) 467
levodopa (423) 423
psychotic disorders - drug therapy (421) 421
drug therapy, combination (419) 419
parkinsons-disease (417) 417
schizophrenic psychology (417) 417
disease models, animal (402) 402
risk factors (396) 396
antipsychotic agents - administration & dosage (383) 383
dopamine (378) 378
adolescent (376) 376
double-blind method (366) 366
dyskinesia, drug-induced - epidemiology (353) 353
psychiatric status rating scales (345) 345
parkinson disease - physiopathology (342) 342
time factors (334) 334
dyskinesia, drug-induced - prevention & control (333) 333
basal ganglia (326) 326
neurology (305) 305
dyskinesia, drug-induced - metabolism (297) 297
severity of illness index (294) 294
haloperidol (290) 290
double-blind (288) 288
l-dopa (282) 282
drug administration schedule (276) 276
levodopa - administration & dosage (268) 268
rats, sprague-dawley (267) 267
drug therapy (265) 265
dopa (263) 263
dyskinesia, drug-induced - therapy (256) 256
neurologic examination - drug effects (251) 251
levodopa-induced dyskinesias (250) 250
parkinson disease, secondary - chemically induced (246) 246
haloperidol - adverse effects (244) 244
follow-up studies (243) 243
dyskinesia, drug-induced (241) 241
levodopa-induced dyskinesia (240) 240
aged, 80 and over (238) 238
motor fluctuations (235) 235
clinical trials as topic (234) 234
clozapine (232) 232
prevalence (224) 224
dyskinesia, drug-induced - psychology (219) 219
parkinson disease - complications (214) 214
parkinsonian disorders - drug therapy (209) 209
antipsychotic drugs (208) 208
age factors (207) 207
antiparkinson agents - administration & dosage (206) 206
basal ganglia diseases - chemically induced (206) 206
analysis (205) 205
motor activity - drug effects (204) 204
dyskinesias (202) 202
risperidone (195) 195
j ve psychiatry (193) 193
receptors, dopamine - drug effects (191) 191
dyskinesia, drug-induced - complications (190) 190
corpus striatum - drug effects (188) 188
dopamine - metabolism (187) 187
mental disorders - drug therapy (184) 184
neuroleptics (182) 182
care and treatment (180) 180
dystonia (180) 180
chronic disease (179) 179
complications and side effects (179) 179
therapy (178) 178
drugs (177) 177
bipolar disorder - drug therapy (174) 174
diagnosis, differential (173) 173
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Providence Healthcare - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
St. Michael's Hospital - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Periodical Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5309) 5309
German (126) 126
French (105) 105
Spanish (51) 51
Japanese (36) 36
Dutch (22) 22
Polish (21) 21
Russian (20) 20
Chinese (13) 13
Italian (11) 11
Portuguese (10) 10
Czech (9) 9
Danish (7) 7
Hungarian (6) 6
Romanian (5) 5
Finnish (3) 3
Swedish (3) 3
Croatian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Turkish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 2005, Volume 128, Issue Part 10, pp. 2240 - 2249
Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinson's disease after some 6-12... 
Subthalamic nucleus | Parkinson's disease | Deep brain stimulation | Globus pallidus pars interna | Long-term effects | NONHUMAN-PRIMATES | SURGERY | SUBTHALAMIC NUCLEUS STIMULATION | long-term effects | BASAL GANGLIA | GLOBUS-PALLIDUS | NEUROSCIENCES | deep brain stimulation | globus pallidus pars interna | CLINICAL NEUROLOGY | LEVODOPA | MOVEMENT-DISORDERS | MOTOR FLUCTUATIONS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | subthalamic nucleus | COMPLICATIONS | Parkinson Disease - therapy | Motor Activity - physiology | Dyskinesia, Drug-Induced - physiopathology | Follow-Up Studies | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Deep Brain Stimulation - adverse effects | Activities of Daily Living | Antiparkinson Agents - therapeutic use | Time Factors | Adult | Female | Globus Pallidus - physiopathology | Subthalamic Nucleus - physiopathology | Levodopa - therapeutic use | Brain - physiopathology | Treatment Outcome | Electrodes, Implanted | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Dyskinesia, Drug-Induced - therapy | Deep Brain Stimulation - methods | Levodopa - adverse effects | Aged | Levodopa/adverse effects/therapeutic use | Antiparkinson Agents/adverse effects/therapeutic use | Globus Pallidus/physiopathology | Parkinson Disease/drug therapy/physiopathology/therapy | Motor Activity/physiology | Brain/physiopathology | Dyskinesia; Drug-Induced/physiopathology/therapy | Subthalamic Nucleus/physiopathology | Deep Brain Stimulation/adverse effects/methods | Electrodes; Implanted
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2014, Volume 124, Issue 3, pp. 1340 - 1349
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 5, pp. 1463 - 1477
Journal Article
Movement Disorders, ISSN 0885-3185, 11/2013, Volume 28, Issue 13, pp. 1838 - 1846
Journal Article
Movement Disorders, ISSN 0885-3185, 05/2015, Volume 30, Issue 6, pp. 788 - 795
Journal Article